---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-22-073063"
form_type: "8-K"
ticker: "KPRX"
cik: "0001372514"
company_name: "KIORA PHARMACEUTICALS INC"
filed_at: "2022-06-21T23:59:59+00:00"
generated_at: "2026-06-25T00:18:27.644749+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Interim CFO Susan L. Drexler resigns; CEO assumes principal financial officer role

## Summary
- Susan L. Drexler resigned as Interim CFO effective June 16, 2022, but remains a consultant.
- Resignation not due to any disagreement with company operations, policies, or practices.
- CEO Brian M. Strem, Ph.D., becomes principal financial and accounting officer.

## SEC filing metadata
- accession: 0001104659-22-073063
- form_type: 8-K
- ticker: KPRX
- cik: 0001372514
- company_name: KIORA PHARMACEUTICALS INC
- filed_at: 2022-06-21T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1372514/000110465922073063/0001104659-22-073063-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1372514/000110465922073063/tm2219040d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-22-073063
- JSON: https://secwatch.observer/filing/0001104659-22-073063.json
- Plain text: https://secwatch.observer/filing/0001104659-22-073063.txt

## Key facts
- Executive change
  Brian M. Strem, Ph.D. changed role as principal financial and accounting officer at KIORA PHARMACEUTICALS INC.
  - Action: assumed
  - Role: principal financial and accounting officer
  source text: Brian M. Strem, Ph.D., the Company’s President and Chief Executive Officer, will assume the role of the Company’s principal financial and accounting officer.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1372514/000110465922073063/0001104659-22-073063-index.htm
- Executive change
  Susan L. Drexler resigned as Interim Chief Financial Officer at KIORA PHARMACEUTICALS INC.
  - Action: resigned
  - Role: Interim Chief Financial Officer
  source text: Effective as of June 16, 2022, Ms. Drexler resigned as Interim Chief Financial Officer of the Company
  evidence_url: https://www.sec.gov/Archives/edgar/data/1372514/000110465922073063/0001104659-22-073063-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.